Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Vitale

Showing results (21-30 of 219) with videos related to

Pageof 22
Sort By:
Rheumatology International|June 7, 2015
Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)Francesco La Torre, Maurizio Muratore, Antonio Vitale, et al.
Clinical and Experimental Rheumatology|April 22, 2015
One year in review 2015: Sjögren's syndromeNicoletta Luciano, Valentina Valentini, Andrea Calabrò, et al.
The Israel Medical Association Journal : IMAJ|May 28, 2016
Interleukin-1 Inhibition in Behçet's diseaseAntonio Vitale, Donato Rigante, Giuseppe Lopalco, et al.
Clinical Rheumatology|May 25, 2017
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literatureStefano Gentileschi, Donato Rigante, Antonio Vitale, et al.
The Oncologist|March 20, 2025
Overcoming amplification-mediated resistance to sotorasib by dose re-escalation in KRAS G12C mutant NSCLC: a case reportAntonio Vitale, Emanuele Vita, Alessio Stefani, et al.
Clinical Rheumatology|September 17, 2014
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada diseaseFrancesco Caso, Donato Rigante, Antonio Vitale, et al.
Immunologic Research|January 1, 2015
Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising futureLuca Cantarini, Donato Rigante, Antonio Vitale, et al.
Current Rheumatology Reports|December 30, 2015
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic PerspectivesAntonio Vitale, Jurgen Sota, Donato Rigante, et al.
Mediators of Inflammation|July 18, 2015
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future PerspectivesCinzia Rotondo, Giuseppe Lopalco, Florenzo Iannone, et al.
Clinical Rheumatology|December 12, 2019
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative reviewCarla Gaggiano, Donato Rigante, Gian Marco Tosi, et al.
Pageof 22

Showing results (21-30 of 219) with videos related to

Sort By:
Pageof 22
Rheumatology International|June 7, 2015
Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS)Francesco La Torre, Maurizio Muratore, Antonio Vitale, et al.
Clinical and Experimental Rheumatology|April 22, 2015
One year in review 2015: Sjögren's syndromeNicoletta Luciano, Valentina Valentini, Andrea Calabrò, et al.
The Israel Medical Association Journal : IMAJ|May 28, 2016
Interleukin-1 Inhibition in Behçet's diseaseAntonio Vitale, Donato Rigante, Giuseppe Lopalco, et al.
Clinical Rheumatology|May 25, 2017
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literatureStefano Gentileschi, Donato Rigante, Antonio Vitale, et al.
The Oncologist|March 20, 2025
Overcoming amplification-mediated resistance to sotorasib by dose re-escalation in KRAS G12C mutant NSCLC: a case reportAntonio Vitale, Emanuele Vita, Alessio Stefani, et al.
Clinical Rheumatology|September 17, 2014
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada diseaseFrancesco Caso, Donato Rigante, Antonio Vitale, et al.
Immunologic Research|January 1, 2015
Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising futureLuca Cantarini, Donato Rigante, Antonio Vitale, et al.
Current Rheumatology Reports|December 30, 2015
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic PerspectivesAntonio Vitale, Jurgen Sota, Donato Rigante, et al.
Mediators of Inflammation|July 18, 2015
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future PerspectivesCinzia Rotondo, Giuseppe Lopalco, Florenzo Iannone, et al.
Clinical Rheumatology|December 12, 2019
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative reviewCarla Gaggiano, Donato Rigante, Gian Marco Tosi, et al.
Pageof 22